Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: The VISIONARY Study

Autor: Oddone, F., Tanga, L., Kothy, P., Hollo, G., Faschinger, C., Chen, E., Nemeth, G., Bator, G., Tsorbatzoglou, A., Acs, T., Ferencz, M., Sohajda, Z., Toth, J., Volner, V., Vogt, G., Biro, Z., Facsko, A., Nemes, J., Berta, A., Elek, I., Ng, E., Rossi, G., Rossetti, L., Vetrugno, M., Iester, M., Marchini, G., Scorcia, V., Staurenghi, G., Cagini, C., Salgarello, T., Bettin, P., Figus, M., Scuderi, G. L., De Cilla, S., Grundmane, I., Linavska, N., Volksone, L., Laganovska, G., Baumane, K., Lemij, H., Gundersen, K. G., Zimina, M., Erichev, V., Karlova, E., Zakharova, E., Panova, I., Malyugin, B., Aguirrec, I. R., Lopez-Lopez, F., Valladares, A. M., del Castillo, J. B., Gimenez, R., Vallejo, M. P., Medina, J. G., Lopez, A. A., Torregrosa, S., Loscos, J., Kolko, M., Ansari, E., Broadway, D., Claridge, K., Ruben, S., Kirwan, J., Nita, A., Smith, M., Moosavi, A., King, A. J. W., Kinsella, M.

Publikováno v: Advances in Therapy
Oddone, F, Tanga, L, Kóthy, P, Holló, G, The VISIONARY Study Group, Faschinger, C, Chen, E, Holló, G, Nemeth, G, Bator, G, Tsorbatzoglou, A, Acs, T, Ferencz, M, Sohajda, Z, Toth, J, Volner, V, Vogt, G, Biro, Z, Facskó, A, Nemes, J, Berta, A, Elek, I, Ng, E, Oddone, F, Rossi, G, Rossetti, L, Vetrugno, M, Iester, M, Marchini, G, Scorcia, V, Staurenghi, G, Cagini, C, Salgarello, T, Bettin, P, Figus, M, Scuderi, G L, De Cilla, S, Grundmane, I, Linavska, N, Volksone, L, Laganovska, G, Baumane, K, Lemij, H, Gundersen, K G, Zimina, M, Erichev, V, Karlova, E, Zakharova, E, Panova, I, Malyugin, B & Kolko, M 2020, ' Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy : The VISIONARY Study ', Advances in Therapy, vol. 37, pp. 1436–1451 . https://doi.org/10.1007/s12325-020-01239-8

Introduction: A non-interventional, multicenter, European, prospective evaluation of the effectiveness, tolerability, and safety of a topical preservative-free tafluprost (0.0015%) and timolol (0.5%) fixed-dose combination (PF tafluprost/timolol FC)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b0c08f0efb8e6b54f23bdfa1e07b15a
http://europepmc.org/articles/PMC7140739

Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment

Autor: Oddone, F., Kirwan, J., Lopez-Lopez, F., Zimina, M., Fassari, C., Hollo, G., Faschinger, C., Chen, E., Nemeth, G., Bator, G., Tsorbatzoglou, A., Acs, T., Ferencz, M., Sohajda, Z., Toth, J., Volner, V., Vogt, G., Biro, Z., Facsko, A., Nemes, J., Berta, A., Elek, I., Ng, E., Rossi, G., Rossetti, L., Vetrugno, M., Iester, M., Marchini, G., Scorcia, V., Staurenghi, G., Cagini, C., Salgarello, T., Bettin, P., Figus, M., Scuderi, G. L., De Cilla, S., Grundmane, I., Linavska, N., Volksone, L., Laganovska, G., Baumane, K., Lemij, H., Gundersen, K. G., Erichev, V., Adbulaeva, E., Karlova, E., Zakharova, E., Panova, I., Malyugin, B., Rodriguez-Agirretxe, I., Valladares, A. M., del Castillo, J. B., Gimenez, R., Vallejo, M. P., Garcia-Medina, J. J., Lopez, A. A., Torregrosa, S., Loscos, J., Kolko, M., Ansari, E., Broadway, D., Claridge, K., Ruben, S., Nita, A., Smith, M., Moosavi, A., King, A. J. W., Kinsella, M.

Publikováno v: The VISIONARY Study Group 2022, ' Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension : Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment ', Advances in Therapy, vol. 39, no. 8, pp. 3501-3521 . https://doi.org/10.1007/s12325-022-02166-6

Introduction: The VISIONARY study demonstrated statistically significant intraocular pressure (IOP) reductions with the preservative-free fixed-dose combination of tafluprost 0.0015% and timolol 0.5% (PF tafluprost/timolol FC) in open-angle glaucoma

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6249f0b9c7c70a793a68dd3fa6775d8e
http://hdl.handle.net/11391/1530993

Strategies to Reduce Oxidative Stress in Glaucoma Patients

Autor: Pinazo-Durán, Shoaie-Nia K, Zanón-Moreno V, Sanz-González SM, Del Castillo J B, García-Medina JJ

Publikováno v: CURRENT NEUROPHARMACOLOGY
r-FISABIO. Repositorio Institucional de Producción Científica
instname

Background: Primary open-angle glaucoma (POAG) is a multifactorial pathology involving a variety of pathogenic mechanisms, including oxidative/nitrosative stress. This latter is the consequence of the imbalance between excessive formation and insuffi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::35c5cd22d5740321d7d3a1c19c00bf0b
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=2126

Intraocular lidocaine in phacoemulsification: an endothelium and blood-aqueous barrier permeability study.

Autor: Iradier MT; Department of Ophthalmology, San Carlos University Hospital, Madrid, Spain., Fernandez C, Bohorquez P, Moreno E, del Castillo JB, Garcia J

Publikováno v: Ophthalmology [Ophthalmology] 2000 May; Vol. 107 (5), pp. 896-900; discussion 900-1.

[Sarcomatous carcinoma versus malignant fibrohistiocytoma. Differential diagnosis of a case of cervical presentation].

Autor: Díaz Caparrós F; Servicio de ORL, Hospital de la S. S. Santa M. del Rosell, Cartagena., García Solano J, Calero del Castillo JB, Pérez Guillermo M

Publikováno v: Acta otorrinolaringologica espanola [Acta Otorrinolaringol Esp] 1997 Nov-Dec; Vol. 48 (8), pp. 674-6.